GlySure’s Technology May Break Barrier For Tight Control And Automated Glucose Monitoring
GlySure’s technology enables a healthcare facility to implement tight glycemic control and intensive insulin therapy.
diabetes
Tianyin Pharmaceuticals Receives China’s SFDA Approval for Its Anti-Diabetic Drug Gliclazide
In 2010, there were 95 million cases of diabetes in China, of which, 52 million and 43 million were found in rural and urban areas, respectively.
CeQur Develops Diabetes Compliance Device
An important drawback of current diabetes treatment regimens is patient compliance, particularly for insulin injections that are painful and must also be timely administered.
LifeCare Displays Glucose Level Data In An Ordinary Wristwatch For Diabetic Patients
LifeCare is a medical devices company that has developed a technological platform for continuous glucose monitoring in diabetic patients. The company’s technology is based on […]
Freedom Meditech develops non-invasive Method to Monitor Glucose Levels
Freedom Meditech is a specialized medical devices company that is developing eye-based diabetes diagnosing and glucose monitoring. The current method of finger pricking for measuring […]
OneMedForum 2011 to Feature “Provider As a System” Panel
“The Provider as a System” will discuss how innovations in information management and technology coupled with changes in the business landscape are transforming the delivery of healthcare.
China Analyst Identifies 10 Pharma Stocks with Highest Growth Potential
China Analyst, a financial information website focused on U.S.-listed Chinese stocks, recently released its list of the top 10 pharmaceutical stocks with the highest upside.
Telcare: Diabetes Control for the Digital Age
Telcare, a Bethesda, Md.-based company focused on connecting patients with their doctors via wireless technology, has developed a wireless glucose meter that enables two-way communication between patient and caregiver.
Researchers Develop Implantable Glucose Monitoring Device for Diabetics
Researchers at the University of California San Diego and GlySens Inc. are developing an implantable wireless sensor to continuously monitor blood sugar in diabetes patients, Reuters reports.
Cholesterol Drugs May Slow Diabetic Vision Loss, Study Finds
A large-scale study funded by the National Institutes of Health found that both blood sugar control and a combination of cholesterol-lowering lipid drugs were effective in slowing the progression of diabetic retinopathy.